Table 1 Mutation frequencies of 25 myeloid genes

From: Incorporation of mutations in five genes in the revised International Prognostic Scoring System can improve risk stratification in the patients with myelodysplastic syndrome

Variables

No. examined

Mutated no.

Percentage (%)

RAS signaling pathway

426

37

8.7

ā€ƒNRAS

426

19

4.5

ā€ƒKRAS

426

6

1.4

ā€ƒCBL

426

13

3.1

Receptors/kinases

426

9

2.1

ā€ƒFLT3/ITD

426

5

1.2

ā€ƒJAK2

426

4

0.9

Transcription

426

61

14.3

ā€ƒRUNX1

426

52

12.2

ā€ƒGATA2

426

11

2.6

DNA methylation

426

104

24.4

ā€ƒIDH1

426

4

0.9

ā€ƒIDH2

426

18

4.2

ā€ƒDNMT3A

426

42

9.9

ā€ƒTET2

426

59

13.8

Chromatin modification

426

103

24.2

ā€ƒASXL1

426

96

22.5

ā€ƒEZH2

426

27

6.3

ā€ƒMLL/PTD

426

5

1.2

RNA splicing

426

166

39

ā€ƒU2AF1

426

31

7.3

ā€ƒSRSF2

426

58

13.6

ā€ƒSF3B1

426

47

11.0

ā€ƒZRSR2

426

41

9.6

Cohesin

426

31

7.3

ā€ƒRAD21

426

0

0

ā€ƒSTAG1

426

2

0.5

ā€ƒSTAG2

426

27

6.3

ā€ƒSMC1A

426

2

0.5

ā€ƒSMC3

426

0

0

Others

426

55

12.9

ā€ƒSETBP1

426

14

3.3

ā€ƒTP53

426

41

9.6